French pharmaceutical giant Sanofi announced Monday that it will acquire U.S.-based Blueprint Medicines for $9.1 billion to strengthen its portfolio in rare immunological diseases.
France-based pharmaceutical company Sanofi announced Monday that it will acquire U.S.-based Blueprint Medicines Corporation for $9.1 billion, in a strategic move to bolster its presence in rare immunological diseases.
Blueprint, a biopharmaceutical company specializing in systemic mastocytosis (SM) and other KIT-driven diseases, accepted Sanofi’s offer of $129 per share in cash. The offer represents a 27% premium over Blueprint’s last closing price of $101.35 on Friday.
The acquisition includes Ayvakit (avapritinib), a treatment for SM approved in both the U.S. and EU, along with a robust early- and late-stage immunology pipeline.
“Blueprint’s established relationships with allergists, dermatologists, and immunologists are expected to enhance Sanofi’s growing immunology portfolio,” the French company said in a statement.
The transaction is expected to close in the third quarter of 2025, pending regulatory approvals.
As part of the deal, Blueprint shareholders will also receive one non-tradeable contingent value right (CVR), entitling them to potential milestone payments of $2 and $4 per CVR based on future achievements.
Blueprint is currently the only company with an approved drug for systemic mastocytosis - a rare disorder caused by excess mast cells - and is also developing next-generation therapies for SM and other immune disorders.
The acquisition marks the largest healthcare M&A deal in Europe so far this year. It follows Sanofi’s recent purchase of Vigil Neuroscience for $470 million last month - the second time the French company has acquired Vigil in 2025, after an initial purchase in January.
Kremlin aide Yuri Ushakov has confirmed that the proposed peace plan was not discussed during recent talks in Abu Dhabi. Despite speculation surroundi...
A fire engulfed a residential building in Hong Kong's northern Tai Po district on Wednesday afternoon, with thick grey smoke billowing from the scene....
British finance minister Rachel Reeves is likely to announce tens of billions of pounds of new tax increases on Wednesday in a budget that puts her cr...
Russian President Vladimir Putin was welcomed in Bishkek on Wednesday as he began a three-day state visit to Kyrgyzstan ahead of a Collective Security...
Two 15-year-olds have asked Australia’s High Court to strike down a forthcoming ban on social media use by under-16s, arguing the law breaches the c...
Kremlin aide Yuri Ushakov has confirmed that the proposed peace plan was not discussed during recent talks in Abu Dhabi. Despite speculation surrounding the meeting, Ushakov clarified that the key topic of peace negotiations was not on the agenda.
A fire engulfed a residential building in Hong Kong's northern Tai Po district on Wednesday afternoon, with thick grey smoke billowing from the scene.
Russian President Vladimir Putin was welcomed in Bishkek on Wednesday as he began a three-day state visit to Kyrgyzstan ahead of a Collective Security Treaty Organisation summit.
Two 15-year-olds have asked Australia’s High Court to strike down a forthcoming ban on social media use by under-16s, arguing the law breaches the country’s implied freedom of political communication ahead of its 10 December start.
The Hayli Gubbi volcano in north-eastern Ethiopia erupted on Sunday for the first time in over 12,000 years, before halting on Monday, according to the Toulouse Volcanic Ash Advisory Center.
Venezuela says it has deployed a range of weapons, including decades-old Russian-made equipment, and plans to mount guerrilla-style resistance in the event of an air or ground assault particularly from the U.S.
U.S. President Donald Trump has told his advisers that he plans to speak directly with Venezuelan President Nicolas Maduro according to Axios, as Washington designated him as the head of a terrorist organisation on Monday. A claim Maduro denies.
Chinese President Xi Jinping has once again expressed strong support for Venezuelan President Nicolás Maduro, condemning foreign interference and criticising U.S. actions in the region.
The United States is preparing to launch a new phase of Venezuela-related operations in the coming days, four U.S. officials told Reuters, as the Trump administration escalates pressure on President Nicolas Maduro.
China has overtaken the United States in the volume of medical research it publishes, showing a major shift in global scientific influence, according to the chief editorial leadership of Swiss-based scientific publisher Frontiers.
A recent study shows that women face a higher risk of job loss due to artificial intelligence (AI) and are 20% less likely than men to use generative AI tools, reducing their chances of working in AI-reliant roles.
There are 29 confirmed cases of the mpox virus in Portugal according to local authorities, which reported in the past three months that there were 10 people in August, three in September, and 16 others in October.
A prostate cancer blood test has been shown to reduce the risk of dying from the disease by 13% over two decades, researchers say.
Serious cases of a disorder of the large intestine are surging among Americans younger than 50, researchers say.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment